Skip to main content
Equibles

Russell Investments Group, Ltd.

Position in ANIK — Anika Therapeutics, Inc.

CIK 1692234 Seattle, WA
Back to ANIK Full portfolio

Position in ANIK

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$123,023
+$76,000 QoQ
Shares Held
8,409
+159.3% QoQ
Ownership
0.063%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#80
of 134 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 97% Shared 0% None 3%

Common Shares in ANIK Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Russell Investments Group, Ltd. holds $362,370,004 across 49 Drug Manufacturers - Specialty & Generic names. ANIK ranks #39 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 893,500 $64,206,902
2 NBIX
Neurocrine Biosciences Inc
 329,065 $55,460,607
3 VTRS
Viatris Inc
 3,423,675 $54,367,956
4 UTHR
UNITED THERAPEUTICS Corp
 61,355 $33,243,974
5 ELAN
Elanco Animal Health Inc
 1,112,894 $27,388,318
6 LNTH
Lantheus Holdings, Inc.
 147,146 $16,324,370
7 TEVA
Teva Pharmaceutical Industries Ltd
 427,444 $14,481,798
8 ALKS
Alkermes plc.
 222,624 $11,665,496

All Filings in ANIK

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $123,023 8,409
2026-03-31 $47,023 3,243
2025-12-31 $16,538 1,721
2025-09-30 $18,799 2,000
2025-06-30 $5,617 531
2025-03-31 $6,553 436
2024-12-31 $4,460 271
2024-09-30 $4,174 169
2024-06-30 $1,798 71
2024-03-31 $1,168 46
2023-12-31 $770 34
2023-06-30 $15,639 602
2023-03-31 $18,840 656
2022-12-31 $2,571,587 86,878
2022-09-30 $2,316,715 97,341
2022-06-30 $2,340,050 104,841
2022-03-31 $2,552,203 101,641
2021-12-31 $3,850,433 107,464
2021-09-30 $5,038,932 118,396
2021-06-30 $6,097,006 140,841
2021-03-31 $10,327,577 253,189
2020-12-31 $9,344,424 206,461
2020-09-30 $4,962,562 140,225
2020-06-30 $4,097,401 108,598
2020-03-31 $1,698,577 58,754